Measles Mumps and Rubella Virus Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monovalent, Combination); End User (Hospital, Healthcare Centers, Others), and Geography

Report Code: TIPRE00021900 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Measles is a severe and infectious disease triggered by a virus. Early symptoms of the disease are fever, red eyes, runny nose, and cough. Later, red spots and tiny rashes are observed on skin. Measles is spread by a virus belonging to the paramyxovirus family, genus Morbillivirus. Rubella/German measles, also called three-day measles, is a contagious disease caused by a viral infection in children. Rubella causes a red rash and a mild fever in children; however, infection during pregnancy can lead to miscarriage, fetal death, stillbirth, or birth with congenital malformations.

MARKET DYNAMICS

The measles mumps and rubella virus vaccine market is driving due to the increasing number of incidences and prevalence of the disease and government agencies are funding for measles, mumps and rubella vaccine development. However, side effects of vaccines is expected to hamper the growth of the global measles mumps and rubella virus vaccine market.

MARKET SCOPE

The "Measles Mumps and Rubella Virus Vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of measles mumps and rubella virus vaccine market with detailed market segmentation by end user and product type. The measles mumps and rubella virus vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in measles mumps and rubella virus vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The measles mumps and rubella virus vaccine market is segmented on the basis of product type and end user. Based on type, the market is segmented as monovalent and combination. On the basis of end user, the market is categorized as hospital, healthcare centers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Measles mumps and rubella virus vaccine market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Measles mumps and rubella virus vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Measles mumps and rubella virus vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Measles mumps and rubella virus vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Measles mumps and rubella virus vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Measles mumps and rubella virus vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Measles mumps and rubella virus vaccine in the global market. Below mentioned is the list of few companies engaged in the Measles mumps and rubella virus vaccine market.

The report also includes the profiles of key players in Measles mumps and rubella virus vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   GSK
  •   Merck & Co., Inc.
  •   Pfizer
  •   Sanofi
  •   Bavarian Nordic
  •   CSL Limited
  •   Emergent Biosolutions
  •   Johnson and Johnson
  •   Novartis
  •   Serum Institute of India

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Measles Mumps And Rubella Virus Vaccine Market - By Product Type
1.3.2 Measles Mumps And Rubella Virus Vaccine Market - By End User
1.3.3 Measles Mumps And Rubella Virus Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MEASLES MUMPS AND RUBELLA VIRUS VACCINE - GLOBAL MARKET OVERVIEW
6.2. MEASLES MUMPS AND RUBELLA VIRUS VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT
7.3.1. Overview
7.3.2. Monovalent Market Forecast and Analysis
7.4. COMBINATION
7.4.1. Overview
7.4.2. Combination Market Forecast and Analysis
8. MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. HEALTHCARE CENTERS
8.4.1. Overview
8.4.2. Healthcare Centers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Measles Mumps And Rubella Virus Vaccine Market Overview
9.1.2 North America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis
9.1.3 North America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Product Type
9.1.4 North America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By End User
9.1.5 North America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Measles Mumps And Rubella Virus Vaccine Market
9.1.5.1.1 United States Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.1.5.1.2 United States Measles Mumps And Rubella Virus Vaccine Market by End User
9.1.5.2 Canada Measles Mumps And Rubella Virus Vaccine Market
9.1.5.2.1 Canada Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.1.5.2.2 Canada Measles Mumps And Rubella Virus Vaccine Market by End User
9.1.5.3 Mexico Measles Mumps And Rubella Virus Vaccine Market
9.1.5.3.1 Mexico Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.1.5.3.2 Mexico Measles Mumps And Rubella Virus Vaccine Market by End User
9.2. EUROPE
9.2.1 Europe Measles Mumps And Rubella Virus Vaccine Market Overview
9.2.2 Europe Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis
9.2.3 Europe Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Product Type
9.2.4 Europe Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By End User
9.2.5 Europe Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Measles Mumps And Rubella Virus Vaccine Market
9.2.5.1.1 Germany Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.2.5.1.2 Germany Measles Mumps And Rubella Virus Vaccine Market by End User
9.2.5.2 France Measles Mumps And Rubella Virus Vaccine Market
9.2.5.2.1 France Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.2.5.2.2 France Measles Mumps And Rubella Virus Vaccine Market by End User
9.2.5.3 Italy Measles Mumps And Rubella Virus Vaccine Market
9.2.5.3.1 Italy Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.2.5.3.2 Italy Measles Mumps And Rubella Virus Vaccine Market by End User
9.2.5.4 Spain Measles Mumps And Rubella Virus Vaccine Market
9.2.5.4.1 Spain Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.2.5.4.2 Spain Measles Mumps And Rubella Virus Vaccine Market by End User
9.2.5.5 United Kingdom Measles Mumps And Rubella Virus Vaccine Market
9.2.5.5.1 United Kingdom Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.2.5.5.2 United Kingdom Measles Mumps And Rubella Virus Vaccine Market by End User
9.2.5.6 Rest of Europe Measles Mumps And Rubella Virus Vaccine Market
9.2.5.6.1 Rest of Europe Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.2.5.6.2 Rest of Europe Measles Mumps And Rubella Virus Vaccine Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market Overview
9.3.2 Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Measles Mumps And Rubella Virus Vaccine Market
9.3.5.1.1 Australia Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.3.5.1.2 Australia Measles Mumps And Rubella Virus Vaccine Market by End User
9.3.5.2 China Measles Mumps And Rubella Virus Vaccine Market
9.3.5.2.1 China Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.3.5.2.2 China Measles Mumps And Rubella Virus Vaccine Market by End User
9.3.5.3 India Measles Mumps And Rubella Virus Vaccine Market
9.3.5.3.1 India Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.3.5.3.2 India Measles Mumps And Rubella Virus Vaccine Market by End User
9.3.5.4 Japan Measles Mumps And Rubella Virus Vaccine Market
9.3.5.4.1 Japan Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.3.5.4.2 Japan Measles Mumps And Rubella Virus Vaccine Market by End User
9.3.5.5 South Korea Measles Mumps And Rubella Virus Vaccine Market
9.3.5.5.1 South Korea Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.3.5.5.2 South Korea Measles Mumps And Rubella Virus Vaccine Market by End User
9.3.5.6 Rest of Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Measles Mumps And Rubella Virus Vaccine Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market Overview
9.4.2 Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Measles Mumps And Rubella Virus Vaccine Market
9.4.5.1.1 South Africa Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.4.5.1.2 South Africa Measles Mumps And Rubella Virus Vaccine Market by End User
9.4.5.2 Saudi Arabia Measles Mumps And Rubella Virus Vaccine Market
9.4.5.2.1 Saudi Arabia Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.4.5.2.2 Saudi Arabia Measles Mumps And Rubella Virus Vaccine Market by End User
9.4.5.3 U.A.E Measles Mumps And Rubella Virus Vaccine Market
9.4.5.3.1 U.A.E Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.4.5.3.2 U.A.E Measles Mumps And Rubella Virus Vaccine Market by End User
9.4.5.4 Rest of Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Measles Mumps And Rubella Virus Vaccine Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Measles Mumps And Rubella Virus Vaccine Market Overview
9.5.2 South and Central America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By End User
9.5.5 South and Central America Measles Mumps And Rubella Virus Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Measles Mumps And Rubella Virus Vaccine Market
9.5.5.1.1 Brazil Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.5.5.1.2 Brazil Measles Mumps And Rubella Virus Vaccine Market by End User
9.5.5.2 Argentina Measles Mumps And Rubella Virus Vaccine Market
9.5.5.2.1 Argentina Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.5.5.2.2 Argentina Measles Mumps And Rubella Virus Vaccine Market by End User
9.5.5.3 Rest of South and Central America Measles Mumps And Rubella Virus Vaccine Market
9.5.5.3.1 Rest of South and Central America Measles Mumps And Rubella Virus Vaccine Market by Product Type
9.5.5.3.2 Rest of South and Central America Measles Mumps And Rubella Virus Vaccine Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MEASLES MUMPS AND RUBELLA VIRUS VACCINE MARKET, KEY COMPANY PROFILES
12.1. GSK
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK AND CO., INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAVARIAN NORDIC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CSL LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. EMERGENT BIOSOLUTIONS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JOHNSON AND JOHNSON
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVARTIS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SERUM INSTITUTE OF INDIA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GSK
2. Merck & Co., Inc.
3. Pfizer
4. Sanofi
5. Bavarian Nordic
6. CSL Limited
7. Emergent Biosolutions
8. Johnson and Johnson
9. Novartis
10. Serum Institute of India
11. Bionic Pharmaceuticals
12. HLL Biotech Limited
13. Sujame Life Science Private Limited
14. Congruent Pharmachem Private Limited
15. JC Medical
16. China National Biotec Group Comp. Ltd.
17. MedImmune LLC
TIPRE00021900
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking